“EVALUATION OF RISK OF MALIGNANCY INDICES 1, 2, AND 3 IN PRE-OPERATIVE ASSESSMENT OF THE OVARIAN MASSES” (2022) Journal of Pharmaceutical Negative Results, pp. 3275–3282. doi:10.47750/pnr.2022.13.S08.402.